Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose

American Journal of Medicine

Volumn 126, Issue 11, 2013, Pages 1017.e1-1017.e10

  Lin, Cheng Chieh ^a,b   Chen, Ching Chu ^a,c   Chen, Fei Na ^b   Li, Chia Ing ^a,b   Liu, Chiu Shong ^a,b   Lin, Wen Yuan ^a,b   Yang, Sing Yu ^c   Lee, Cheng Chun ^a,b   Li, Tsai Chung ^c,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Diabetic nephropathy; Fasting plasma glucose; Type 2 diabetes

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FUNCTION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; BLOOD; COMPLICATION; DIABETIC NEPHROPATHIES; FOLLOW UP; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84886439995     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.04.015     Document Type: Article

References (26)

1. A. Levin, O. Djurdjev, and B. Barrett Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter Am J Kidney Dis 38 2001 1398 1407
2. H.M. Colhoun, E.T. Lee, and P.H. Bennett Risk factors for renal failure: the WHO Multinational Study of Vascular Disease in Diabetes Diabetologia 44 Suppl 2 2001 S46 S53
3. US Renal Data System USRDS 2004 Annual Data Report Am J Kidney Dis 45 Suppl 1 2005 S8 S80
4. US Renal Data System USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2009 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
5. R.G. Nelson, P.H. Bennett, and G.J. Beck Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus: diabetic renal disease study group N Engl J Med 335 1996 1636 1642
6. L.L. Humphrey, D.J. Ballard, P.P. Frohnert, C.P. Chu, W.M. O'Fallon, and P.J. Palumbo Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota Ann Intern Med 111 1989 788 796
7. Department of Health and Executive Yuan: Annual Statistics Report, Republic of China, 2002-2006. Available at: http://www.doh.gov.tw/CHT2006/DM/ DM2-2.aspx?now-fod-list-no=10124&class-no=440&level-no=4. Accessed November 11, 2010.
8. H.Y. Chang, W.T. Yeh, Y.H. Chang, K.S. Tsai, and W.H. Pan Prevalence of dyslipidemia and mean blood lipid values in Taiwan: results from the Nutrition and Health Survey in Taiwan (NAHSIT, 1993-1996) Chin J Physiol 45 2002 187 197
9. Department of Health and Executive Yuan: The prevalence of type 2 diabetes mellitus. Department of Health, Taiwan 2009. Available at: http://www.doh.gov.tw/EN2006/index-EN.aspx. Accessed November 11, 2010.
10. A. Ceriello, and M.A. Ihnat 'Glycemic variability': a new therapeutic challenge in diabetes and the critical care setting Diabet Med 27 2010 862 867
11. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of longer complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
12. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes Lancet 352 1998 837 853
13. C. Stettler, S. Allemann, and P. Jüni Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials Am Heart J 152 2006 27 38
14. F. de Vegt, J.M. Dekker, and H.G. Ruhé Hyperglycaemia is associated with all cause and cardiovascular mortality in the Hoorn population: the Hoorn Study Diabetologia 42 1999 926 931
15. DECODE Study Group Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria Arch Intern Med 161 2001 397 405
16. J.D. Sorkin, D.C. Muller, J.L. Fleg, and R. Andres The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature Diabetes Care 28 2005 2626 2632
17. C.M. Lawes, V. Parag, D.A. Bennett Asia Pacific Cohort Studies Collaboration Blood glucose and risk of cardiovascular disease in the Asia Pacific region Diabetes Care 27 2004 2836 2842
18. E.S. Kilpatrick, A.S. Rigby, and S.L. Atkin A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial Diabetes Care 31 2008 2198 2202
19. A. Ceriello, K. Esposito, and L. Piconi Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients Diabetes 57 2008 1349 1354
20. M. Muggeo, G. Verlato, and E. Bonora The Verona Diabetes Study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality Diabetologia 38 1995 318 325
21. M. Muggeo, G. Verlato, and E. Bonora Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study Diabetologia 38 1995 672 679
22. M. Muggeo, G. Zoppini, and E. Bonora Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study Diabetes Care 23 2000 45 50
23. A.S. Levey, L.A. Stevens, C.H. Schmid CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
24. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 Suppl 1 2002 S1 S266
25. P. Fioretto, M. Mauer, and E. Brocco Patterns of renal injury in NIDDM patients with microalbuminuria Diabetologia 39 1996 1569 1576
26. S.C. Jones, H.J. Saunders, W. Qi, and C.A. Pollock Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells Diabetologia 42 1999 1113 1119